FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2050513777> ?p ?o ?g. }

• W2050513777 endingPage "389" @default.
• W2050513777 startingPage "385" @default.
• W2050513777 abstract "Abstract. Purpose: To evaluate the effects of panretinal photocoagulation (PRP) compared with PRP plus intravitreal bevacizumab on best corrected visual acuity (BCVA) and total area of fluorescein leakage from active new vessels (NVs) in patients with high‐risk proliferative diabetic retinopathy (PDR). Methods: We carried out a prospective study of patients with high‐risk PDR and no prior laser treatment who were randomly assigned to receive PRP (PRP group) or PRP plus intravitreal injection of 1.5 mg of bevacizumab (PRP‐plus group). In all patients, the PRP was administered at two time‐points (weeks 1 and 3), with the intravitreal bevacizumab delivered at the end of the second laser episode in the PRP‐plus group. Standardized ophthalmic evaluation including Early Treatment Diabetic Retinopathy Study BCVA as well as stereoscopic fundus photography and fluorescein angiography were performed at baseline and at weeks 4, 9 (± 1) and 16 (± 2). Main outcome measures included changes in BCVA and in total area of fluorescein leakage from active NVs. Results: Twenty‐two ( n = 30 eyes) consecutive patients completed the 16‐week follow‐up. There was no significant difference between the PRP and PRP‐plus groups with respect to age, gender, type or duration of diabetes, area of fluorescein leakage from active NVs or BCVA. No significant difference in BCVA was observed between the groups throughout the study period. However, the total area of actively leaking NVs was significantly reduced in the PRP‐plus group compared with the PRP group at weeks 4, 9 and 16 (p < 0.001). No major adverse events were identified. Conclusions: In the short‐term, the adjunctive use of intravitreal bevacizumab with PRP was associated with a greater reduction in the area of active leaking NVs than PRP alone in patients with high‐risk PDR." @default.
• W2050513777 created "2016-06-24" @default.
• W2050513777 creator A5046746381 @default.
• W2050513777 creator A5048508222 @default.
• W2050513777 creator A5049713908 @default.
• W2050513777 creator A5062115774 @default.
• W2050513777 creator A5063748035 @default.
• W2050513777 creator A5077460225 @default.
• W2050513777 date "2008-06-01" @default.
• W2050513777 modified "2023-10-16" @default.
• W2050513777 title "Panretinal photocoagulation versus PRP plus intravitreal bevacizumab for high-risk proliferative diabetic retinopathy (IBeHi study)" @default.
• W2050513777 cites W1214250537 @default.
• W2050513777 cites W1526282761 @default.
• W2050513777 cites W1978139448 @default.
• W2050513777 cites W1980481418 @default.
• W2050513777 cites W1986929568 @default.
• W2050513777 cites W1997324775 @default.
• W2050513777 cites W2007910630 @default.
• W2050513777 cites W2011046688 @default.
• W2050513777 cites W2029126623 @default.
• W2050513777 cites W2033680298 @default.
• W2050513777 cites W2037623358 @default.
• W2050513777 cites W2042261909 @default.
• W2050513777 cites W2045390750 @default.
• W2050513777 cites W2047279031 @default.
• W2050513777 cites W2075086348 @default.
• W2050513777 cites W2099838434 @default.
• W2050513777 cites W2114774559 @default.
• W2050513777 cites W2122595579 @default.
• W2050513777 cites W2137893922 @default.
• W2050513777 cites W2156121263 @default.
• W2050513777 cites W2324588265 @default.
• W2050513777 cites W2406931263 @default.
• W2050513777 cites W4244248663 @default.
• W2050513777 cites W4248345319 @default.
• W2050513777 cites W4248872298 @default.
• W2050513777 cites W4255957248 @default.
• W2050513777 doi "https://doi.org/10.1111/j.1600-0420.2007.01056.x" @default.
• W2050513777 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/17995982" @default.
• W2050513777 hasPublicationYear "2008" @default.
• W2050513777 type Work @default.
• W2050513777 sameAs 2050513777 @default.
• W2050513777 citedByCount "113" @default.
• W2050513777 countsByYear W20505137772012 @default.
• W2050513777 countsByYear W20505137772013 @default.
• W2050513777 countsByYear W20505137772014 @default.
• W2050513777 countsByYear W20505137772015 @default.
• W2050513777 countsByYear W20505137772016 @default.
• W2050513777 countsByYear W20505137772017 @default.
• W2050513777 countsByYear W20505137772018 @default.
• W2050513777 countsByYear W20505137772019 @default.
• W2050513777 countsByYear W20505137772020 @default.
• W2050513777 countsByYear W20505137772021 @default.
• W2050513777 countsByYear W20505137772022 @default.
• W2050513777 countsByYear W20505137772023 @default.
• W2050513777 crossrefType "journal-article" @default.
• W2050513777 hasAuthorship W2050513777A5046746381 @default.
• W2050513777 hasAuthorship W2050513777A5048508222 @default.
• W2050513777 hasAuthorship W2050513777A5049713908 @default.
• W2050513777 hasAuthorship W2050513777A5062115774 @default.
• W2050513777 hasAuthorship W2050513777A5063748035 @default.
• W2050513777 hasAuthorship W2050513777A5077460225 @default.
• W2050513777 hasConcept C118487528 @default.
• W2050513777 hasConcept C121332964 @default.
• W2050513777 hasConcept C134018914 @default.
• W2050513777 hasConcept C141071460 @default.
• W2050513777 hasConcept C188816634 @default.
• W2050513777 hasConcept C2776391266 @default.
• W2050513777 hasConcept C2776474195 @default.
• W2050513777 hasConcept C2776694085 @default.
• W2050513777 hasConcept C2777802072 @default.
• W2050513777 hasConcept C2778015030 @default.
• W2050513777 hasConcept C2778257484 @default.
• W2050513777 hasConcept C2779829184 @default.
• W2050513777 hasConcept C2780248432 @default.
• W2050513777 hasConcept C2908627140 @default.
• W2050513777 hasConcept C555293320 @default.
• W2050513777 hasConcept C62520636 @default.
• W2050513777 hasConcept C71924100 @default.
• W2050513777 hasConcept C91881484 @default.
• W2050513777 hasConceptScore W2050513777C118487528 @default.
• W2050513777 hasConceptScore W2050513777C121332964 @default.
• W2050513777 hasConceptScore W2050513777C134018914 @default.
• W2050513777 hasConceptScore W2050513777C141071460 @default.
• W2050513777 hasConceptScore W2050513777C188816634 @default.
• W2050513777 hasConceptScore W2050513777C2776391266 @default.
• W2050513777 hasConceptScore W2050513777C2776474195 @default.
• W2050513777 hasConceptScore W2050513777C2776694085 @default.
• W2050513777 hasConceptScore W2050513777C2777802072 @default.
• W2050513777 hasConceptScore W2050513777C2778015030 @default.
• W2050513777 hasConceptScore W2050513777C2778257484 @default.
• W2050513777 hasConceptScore W2050513777C2779829184 @default.
• W2050513777 hasConceptScore W2050513777C2780248432 @default.
• W2050513777 hasConceptScore W2050513777C2908627140 @default.
• W2050513777 hasConceptScore W2050513777C555293320 @default.
• W2050513777 hasConceptScore W2050513777C62520636 @default.
• W2050513777 hasConceptScore W2050513777C71924100 @default.
• W2050513777 hasConceptScore W2050513777C91881484 @default.

• next